LAUREN CUSUMANO: Open Payments
NPI 1669100384 · MINEOLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 15 payments from 6 companies in 2025. Trend: 2023 $142 · 2024 $155 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $147 |
| Alnylam Pharmaceuticals Inc. | 5 | $114 |
| BridgeBio Pharma, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Abbott Laboratories | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: WAINUA, AMVUTTRA, Attruby, LEQVIO, CARDIOMEMS.
Industry payments across NY — which companies pay providers there.
